Delhi NCR-based pain care startup Zanskar is in talks to raise about $6 Mn in a fresh funding round led by Bessemer Venture Partners, sources told Inc42.
The funding comes less than a year after Zanskar raised its seed round and underscores continued investor interest in startups building technology-led chronic pain management solutions
The final cheque size could change before the round is closed, the sources added
Delhi NCR-based pain care startup Zanskar
is in talks to raise about $6 Mn in a fresh funding round led by Bessemer Venture Partners, sources told Inc42.
The discussions are ongoing and final cheque size could change before the round is closed, the sources added.
Zanskar and Bessemer Venture Partners did not respond to Inc42’s queries till the time of publication.
The development comes about 10 months after the startup raised ₹2.8 Cr in a seed funding round led by Zeropearl VC, with participation from angel investors including Fashinza cofounder Pawan Gupta, 10X Growth Ventures managing partner Amit Baid, and Oaktree Capital SVP Nidhish Mundra.
Founded in 2022 by IIT Delhi alumni Anshul Mittal and Manu Kumar Mittal, Zanskar operates a technology-led pain management platform offering personalised at-home care protocols through its app. It also sells pain relief products, including oils, roll-ons, and nutritional supplements, through its website and ecommerce platforms such as Blinkit, Tata 1mg, Amazon, and Flipkart.
Earlier, the startup said it was exploring pilots for physiotherapy-led wellness centres in select metro cities as part of its broader pain management ecosystem.
The fundraise comes amid growing investor interest in startups tackling chronic pain management. Earlier this year, Nivaan Care raised $7 Mn in a Series A funding round led by Sorin Investments with participation from W Health Ventures and other investors. Last year, FlexifyMe secured ₹20 Cr in a pre-Series A round to expand its online physiotherapy platform for chronic pain management.
According to a report, nearly 47% of Indians aged 45 and above experience joint pain, while about 31% suffer from persistent back pain. The report added that untreated chronic pain and prolonged dependence on painkillers can lead to disability and other serious health complications.
According to Inc42’s ‘Annual Indian Startup Trends Report, 2025’, the market for healthtech is projected to grow at 39% CAGR from 2025 to cross the $37 Bn+ mark by 2030. However, funding activity remained muted, with the number of deals falling to 54 in 2025 from 78 a year earlier.
Source: Inc42 - Startups
